Gozansky W S, Lynn J S, Laudenslager M L, Kohrt W M
Division of Geriatric Medicine, Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA.
Clin Endocrinol (Oxf). 2005 Sep;63(3):336-41. doi: 10.1111/j.1365-2265.2005.02349.x.
The aim of this study was to determine whether salivary cortisol measured by a simple enzyme immunoassay (EIA) could be used as a surrogate for serum total cortisol in response to rapid changes and across a wide range of concentrations.
Comparisons of matched salivary and serum samples in response to dynamic hypothalamic-pituitary-adrenal (HPA) axis testing. Subjects Healthy women (n=10; three taking oral oestrogens) and men (n=2), aged 23--65 years, were recruited from the community. Measurements Paired saliva and serum samples were obtained during three protocols: 10 min of exercise at 90% of maximal heart rate (n=8), intravenous administration of corticotrophin-releasing hormone (CRH; n=4), and dexamethasone suppression (n=7). Cortisol was measured in saliva using a commercial high-sensitivity EIA and total cortisol was measured in serum with a commercial radioimmunoassay (RIA). Results The time course of the salivary cortisol response to both the exercise and CRH tests paralleled that of total serum cortisol. Salivary cortisol demonstrated a significantly greater relative increase in response to the exercise and CRH stimuli (697+/- 826%vs. 209+/- 150%, P=0.04 saliva vs. serum). A disproportionately larger increase in free cortisol, compared with total, would be expected when the binding capacity of cortisol-binding globulin (CBG) is exceeded. In response to dexamethasone suppression, relative decreases in cortisol were not significantly different between the two media (-47+/- 56%vs.-84+/- 8%, P=0.13 saliva vs. serum). Although a significant linear correlation was found for all paired salivary and serum total cortisol samples (n=183 pairs, r=0.60, P<0.001), an exponential model provided a better fit (r=0.81, P<0.001). The linear correlations were strengthened when data from subjects on oral oestrogens (n=52 pairs, r=0.75, P < 0.001) were separated from those not taking oestrogens (n=131 pairs, r=0.67, P<0.001). Conclusions Salivary cortisol measured with a simple EIA can be used in place of serum total cortisol in physiological research protocols. Evidence that salivary measures represent the biologically active, free fraction of cortisol includes: (1) the greater relative increase in salivary cortisol in response to tests that raise the absolute cortisol concentration above the saturation point of CBG; (2) the strong exponential relationship between cortisol assessed in the two media; and (3) the improved linear correlations when subjects known to have increased CBG were analysed separately. Thus, an advantage of measuring salivary cortisol rather than total serum cortisol is that it eliminates the need to account for within-subject changes or between-subject differences in CBG.
本研究旨在确定通过简单酶免疫测定法(EIA)测量的唾液皮质醇是否可作为血清总皮质醇的替代指标,以应对快速变化并涵盖广泛的浓度范围。
对动态下丘脑 - 垂体 - 肾上腺(HPA)轴测试中匹配的唾液和血清样本进行比较。
从社区招募了年龄在23 - 65岁的健康女性(n = 10;3名服用口服雌激素)和男性(n = 2)。
在三个实验方案中获取配对的唾液和血清样本:以最大心率的90%进行10分钟运动(n = 8)、静脉注射促肾上腺皮质激素释放激素(CRH;n = 4)以及地塞米松抑制实验(n = 7)。使用商业高灵敏度EIA测定唾液中的皮质醇,使用商业放射免疫测定法(RIA)测定血清中的总皮质醇。
运动和CRH测试中唾液皮质醇反应的时间进程与血清总皮质醇的时间进程平行。唾液皮质醇对运动和CRH刺激的相对增加显著更大(697±826%对209±150%,唾液对血清,P = 0.04)。当皮质醇结合球蛋白(CBG)的结合能力被超过时,游离皮质醇相对于总皮质醇的增加会不成比例地更大。在地塞米松抑制实验中,两种介质中皮质醇的相对降低没有显著差异(-47±56%对-84±8%,唾液对血清,P = 0.13)。尽管在所有配对的唾液和血清总皮质醇样本中发现了显著的线性相关性(n = 183对,r = 0.60,P < 0.001),但指数模型拟合效果更好(r = 0.81,P < 0.001)。当将服用口服雌激素的受试者(n = 52对,r = 0.75,P < 0.001)的数据与未服用雌激素的受试者(n = 131对,r = 0.67,P < 0.001)的数据分开时,线性相关性增强。
在生理研究方案中,用简单EIA测量的唾液皮质醇可替代血清总皮质醇。唾液测量代表皮质醇生物活性游离部分的证据包括:(1)在将绝对皮质醇浓度提高到超过CBG饱和点的测试中,唾液皮质醇的相对增加更大;(2)两种介质中评估的皮质醇之间存在强指数关系;(3)当分别分析已知CBG增加的受试者时,线性相关性得到改善。因此,测量唾液皮质醇而非血清总皮质醇的一个优点是无需考虑个体内CBG的变化或个体间CBG的差异。